Cargando…

Role of Immunosuppression on Efficacy of Anti-SARS-CoV-2 Vaccines in Heart Transplanted (HT) Patients

PURPOSE: Vaccines against COVID-19 have a lower efficacy in HT patients (pts); factors influencing their immunogenicity are unknown. The aim of this study is to investigate the role of immunosuppression on mRNA vaccines efficacy. METHODS: We included all HT pts followed in our Center completing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masetti, M., Aloisio, A., Giovannini, L., Borgese, L., Caroccia, N., Pascale, R., Lazzarotto, T., Giannella, M., Pacini, D., Viale, P., Potena, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	(398)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988650/ http://dx.doi.org/10.1016/j.healun.2022.01.419

Ejemplares similares

Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
por: Masetti, Marco, et al.
Publicado: (2023)

1089. Evaluation of breakthrough infections in solid organ transplant recipients: the prospective CONTRAST cohort
por: Tazza, Beatrice, et al.
Publicado: (2022)

Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

Telemedicine (TM) during SARS-CoV-2 Outbreak
por: Masetti, M., et al.
Publicado: (2021)

Novel therapeutic and diagnostic management of heart transplant patients
por: D'Addio, Francesca, et al.
Publicado: (2015)

Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies
por: Potena, Luciano, et al.
Publicado: (2013)

Proper Left Ventricular Assist Device Outpatients Monitoring: VAD Coordinator Interface Despite COVID-19 Pandemic
por: Boschi, S., et al.
Publicado: (2021)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study
por: D'Andrea, G., et al.
Publicado: (2023)

Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort
por: Giannella, Maddalena, et al.
Publicado: (2022)

New immunosuppressive drugs in heart transplantation
por: Costanzo, Maria Rosa
Publicado: (2001)

Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
por: Giannella, Maddalena, et al.
Publicado: (2023)

Covid-19 in recipients of heart and lung transplantation: Learning from experience
por: Kittleson, Michelle M., et al.
Publicado: (2021)

214. The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis.
por: Rinaldi, Matteo, et al.
Publicado: (2022)

The impact of preservation fluid culture on graft site arteritis: A systematic review and meta‐analysis
por: Rinaldi, Matteo, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

Heart transplantation with generic immunosuppression – a developing country experience
por: Villavicencio, M, et al.
Publicado: (2013)

Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic
por: Rinaldi, Eugenia, et al.
Publicado: (2022)

SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

(62) Heart Transplantation (ht) from Active and Recently Active Covid19 Donors
por: Madan, S., et al.
Publicado: (2023)

Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
por: Chang, David H., et al.
Publicado: (2020)

“SARS-CoV-2 Infection in Liver Transplant Recipients - Immunosuppression is the Silver Lining?”
por: Jadaun, Shekhar S., et al.
Publicado: (2022)

Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation
por: Kim, Hye-Jin, et al.
Publicado: (2022)

Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study
por: Denhaerynck, Kris, et al.
Publicado: (2018)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
por: Asleh, Rabea, et al.
Publicado: (2022)

A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients
por: Nassetta, Keira, et al.
Publicado: (2022)

Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir
por: Rajakumar, Irina, et al.
Publicado: (2021)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014)

Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)

Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants
por: Miller, Emily E., et al.
Publicado: (2018)

SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know
por: Giannella, Maddalena, et al.
Publicado: (2021)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes
por: Genuardi, Michael V., et al.
Publicado: (2021)

(655) Outcomes of Immunosuppression Reduction During Covid-19 Infection in Heart Transplant Patients
por: Sauers, E., et al.
Publicado: (2023)

Targets of new immunosuppressants in renal transplantation
por: Cruzado, Josep M, et al.
Publicado: (2011)

Everolimus Use for Intolerance or Failure of Baseline Immunosuppression in Adult Heart and Lung Transplantation
por: Kelsh, Shelby E., et al.
Publicado: (2018)

Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview
por: Grossi, Paolo, et al.
Publicado: (2016)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_stg8f060v46h6nst7ev6781lpb